Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer.
Missiroli S, Perrone M, Boncompagni C, Borghi C, Campagnaro A, Marchetti F, Anania G, Greco P, Fiorica F, Pinton P, Giorgi C.
Missiroli S, et al. Among authors: borghi c.
Cancers (Basel). 2021 May 11;13(10):2297. doi: 10.3390/cancers13102297.
Cancers (Basel). 2021.
PMID: 34064909
Free PMC article.
Review.